- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Urinary Bladder, Overactive
Total 61003 results
-
Pamukkale UniversityCompletedUrge Incontinence Episodes After the Magnetic Stimulation Added to Bladder Training in Women With Idiopathic Overactive BladderTurkey
-
Meir Medical CenterCompletedOveractive Bladder | Bladder Cancer | SynergoIsrael
-
BayerCompletedOveractive BladderAustria, Singapore, New Zealand, Australia, Portugal, Czechia, Poland, Germany, Sweden
-
Urovant Sciences GmbHCompletedOveractive BladderUnited States, Latvia, Hungary, Canada, Lithuania, Poland
-
Velicept Therapeutics, Inc.CompletedOveractive BladderUnited States
-
Merck Sharp & Dohme LLCCompleted
-
PfizerCompleted
-
BlueWind MedicalWithdrawn
-
Universidad de ValparaisoRecalcine (GynoPharm)CompletedOveractive BladderChile
-
Asan Medical CenterSamsung Medical Center; Seoul National University Hospital; Cheil General Hospital... and other collaboratorsCompletedOveractive BladderKorea, Republic of
-
US Department of Veterans AffairsCompleted
-
AllerganCompletedOveractive BladderPoland, United Kingdom, Belgium, Russian Federation, Czech Republic, Germany, United States
-
Ethicon Endo-SurgeryNovella Clinical; Data & Inference, Inc.CompletedOveractive BladderUnited States, Sweden, United Kingdom
-
Zipper Urogynecology AssociatesUnknown
-
Astellas Pharma IncAstellas Pharma Canada, Inc.Completed
-
APOGEPHA Arzneimittel GmbHCompleted
-
Astellas Pharma Global Development, Inc.TerminatedPharmacokinetics of Mirabegron | Overactive Bladder (OAB)Korea, Republic of, Russian Federation, Turkey
-
University of California, San FranciscoNational Institute on Aging (NIA)CompletedOveractive Bladder | Urgency Incontinence | Urgency Urinary SymptomsUnited States
-
Swiss Paraplegic Centre NottwilCompleted
-
Far Eastern Memorial HospitalNational Science Council, TaiwanCompletedOveractive Bladder Syndrome | Lower Urinary Tract DysfunctionTaiwan
-
Aristotle University Of ThessalonikiRecruiting
-
Urovant Sciences GmbHCompleted
-
Biruni UniversityCompletedOveractive Bladder
-
Women and Infants Hospital of Rhode IslandCompletedOveractive Bladder
-
Liverpool Women's NHS Foundation TrustManchester Metropolitan UniversityCompletedOveractive BladderUnited Kingdom
-
University of PennsylvaniaPfizerCompletedOveractive BladderUnited States
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive BladderPoland, United Kingdom, Germany, Spain, Netherlands, Belgium, Czech Republic, Italy, Norway, Hungary, Sweden, Denmark, Greece, France, Russian Federation
-
AllerganCompletedOveractive BladderCanada, United States
-
PfizerCompletedOveractive BladderUnited States
-
Lee's Pharmaceutical LimitedAPOGEPHA Arzneimittel GmbHCompleted
-
Loyola UniversityCompletedOveractive BladderUnited States
-
Isra UniversityUnknown
-
Velicept Therapeutics, Inc.Completed
-
R-PharmSynergy Research Inc.CompletedOveractive BladderRussian Federation
-
The Hospital of VestfoldSouth-Eastern Norway Regional Health AuthorityCompletedOveractive BladderNorway
-
Mansoura UniversityUnknownOveractive Bladder | Botulinum Toxin | ESWL | IntravesicalEgypt
-
SanofiCompletedOveractive BladderFrance, Germany, Netherlands, Portugal, Czech Republic, United States, Canada
-
Astellas Pharma IncCompletedOveractive Bladder | Cardiovascular DiseaseJapan
-
Assistance Publique - Hôpitaux de ParisCompletedOveractive BladderFrance
-
Kissei Pharmaceutical Co., Ltd.Completed
-
Kissei Pharmaceutical Co., Ltd.WithdrawnOveractive BladderJapan
-
Watson PharmaceuticalsCompleted
-
PfizerCompletedOveractive Bladder With Symptoms of Frequency, Urgency, and Urge Urinary IncontinenceUnited States
-
Cleveland Clinic FloridaAstellas Pharma US, Inc.UnknownOveractive Bladder | Urinary Tract InfectionUnited States
-
Astellas Pharma Europe B.V.Veeda Clinical ResearchCompletedLower Urinary Tract Predominant Storage SymptomsBelgium
-
Assaf-Harofeh Medical CenterUnknownOveractive Bladder Syndrome | Bladder Outlet Obstruction | Benign Prostate Enlargement | Stress Incontinence (Female) (Male) | Bladder DiseaseIsrael
-
University of AarhusUniversity Hospital, GhentUnknown
-
Urovant Sciences GmbHCompletedOveractive Bladder With Urge Urinary IncontinenceUnited States
-
Ludwig-Maximilians - University of MunichRecruitingOveractive Bladder | Lower Urinary Tract Symptoms | Chemotherapy Effect | Chemotherapeutic ToxicityGermany